Company: Teva Pharmaceutical
[1]Starting stock price: $31.26
Ending stock price: $46.48
Percent Change: 48.69%
Details: Generic drug powerhouse Teva Pharmaceuticals had a great year in 2007. The company received FDA approval for 28 new products, including generic versions of Aricept, Requip, Actonel, Coreg, and Protonix. Teva's revenue rose 12 percent year over 2006, which was another blockbuster year for the drugmaker. And with more blockbuster drugs on their way to generics land [2], things can only get better for Teva.
More News:
Teva snaps up CoGenesys in $400M buyout. Report [3]
Teva earmarks $1B for India. Report [4]
Earnings from Schering, Sanofi, Teva. Report [5]
Analysts get bullish on generics makers. Report [6]
Links:
[1] http://www.tevapharm.com/
[2] http://www.fiercepharma.com/story/blockbusters-their-way-generic-land/2008-01-02
[3] http://www.fiercebiotech.com/story/teva-snaps-cogenesys-400m-buyout/2008-01-22
[4] http://www.fiercepharma.com/story/teva-earmarks-1b-india/2008-01-11
[5] http://www.fiercepharma.com/story/earnings-from-schering-sanofi-teva/2008-02-12
[6] http://www.fiercepharma.com/story/analysts-get-bullish-on-generics-makers/2007-12-19?utm_medium=nl&utm_source=link
[7] http://www.fiercepharma.com/special-reports/cleveland-biolabs-best-pharma-stocks-2007
[8] http://www.fiercepharma.com/special-reports/best-pharma-stocks-2007
[9] http://www.fiercepharma.com/special-reports/bentley-pharmaceutical-best-pharma-stocks-2007